Justin Walsh
Stock Analyst at JonesTrading
(4.78)
# 578
Out of 5,004 analysts
394
Total ratings
39.8%
Success rate
22%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics | Reiterated: Buy | $50 | $33.91 | +47.45% | 22 | Sep 18, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $90 | $36.17 | +148.82% | 9 | Sep 15, 2026 | |
| SPTX Seaport Therapeutics | Reiterated: Buy | $32 | $21.52 | +48.70% | 2 | Sep 10, 2026 | |
| RNXT RenovoRx | Reiterated: Buy | $8 | $1.66 | +381.93% | 6 | Aug 19, 2026 | |
| CLNN Clene | Reiterated: Buy | $30 | $4.30 | +597.67% | 15 | Aug 18, 2026 | |
| NMTC NeuroOne Medical Technologies | Reiterated: Buy | $8 | $1.33 | +501.50% | 4 | Aug 18, 2026 | |
| SER Serina Therapeutics | Reiterated: Buy | $11 | $2.09 | +426.32% | 9 | Aug 18, 2026 | |
| ATNM Actinium Pharmaceuticals | Reiterated: Buy | $9 → $3 | $1.20 | +150.00% | 33 | Aug 14, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $18 | $2.52 | +614.29% | 35 | Aug 14, 2026 | |
| LNTH Lantheus Holdings | Reiterated: Hold | n/a | $99.74 | - | 32 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.34 | +153.46% | 15 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $441 | $280.78 | +57.06% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.60 | - | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.85 | - | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $26.49 | +66.10% | 19 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $24 | $0.259 | +9,166.41% | 5 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $7.54 | +165.25% | 23 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $1.65 | +1,718.18% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.52 | - | 27 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $85.24 | n/a | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.99 | n/a | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.40 | $0.01 | n/a | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.90 | n/a | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $1.37 | n/a | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.8299 | n/a | 12 | Jun 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $6.89 | n/a | 15 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $20 | $33.07 | n/a | 2 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.13 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $4.38 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $57.68 | n/a | 2 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 2 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.71 | n/a | 2 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.75 | n/a | 3 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $18.20 | n/a | 5 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $5.58 | n/a | 1 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $1.26 | n/a | 1 | Feb 17, 2021 |
Rapport Therapeutics
Sep 18, 2026
Reiterated: Buy
Price Target: $50
Current: $33.91
Upside: +47.45%
Definium Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $90
Current: $36.17
Upside: +148.82%
Seaport Therapeutics
Sep 10, 2026
Reiterated: Buy
Price Target: $32
Current: $21.52
Upside: +48.70%
RenovoRx
Aug 19, 2026
Reiterated: Buy
Price Target: $8
Current: $1.66
Upside: +381.93%
Clene
Aug 18, 2026
Reiterated: Buy
Price Target: $30
Current: $4.30
Upside: +597.67%
NeuroOne Medical Technologies
Aug 18, 2026
Reiterated: Buy
Price Target: $8
Current: $1.33
Upside: +501.50%
Serina Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $11
Current: $2.09
Upside: +426.32%
Actinium Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: $9 → $3
Current: $1.20
Upside: +150.00%
Perspective Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $18
Current: $2.52
Upside: +614.29%
Lantheus Holdings
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $99.74
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $11
Current: $4.34
Upside: +153.46%
Aug 7, 2026
Reiterated: Buy
Price Target: $441
Current: $280.78
Upside: +57.06%
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $2.60
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $2.85
Upside: -
Jun 26, 2026
Reiterated: Buy
Price Target: $44
Current: $26.49
Upside: +66.10%
May 18, 2026
Reiterated: Buy
Price Target: $60 → $24
Current: $0.259
Upside: +9,166.41%
May 12, 2026
Reiterated: Buy
Price Target: $20
Current: $7.54
Upside: +165.25%
Mar 25, 2026
Reiterated: Buy
Price Target: $30
Current: $1.65
Upside: +1,718.18%
Jan 5, 2026
Rated: Hold
Price Target: n/a
Current: $18.52
Upside: -
May 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $85.24
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.99
Upside: n/a
Oct 30, 2024
Reiterated: Buy
Price Target: $0.40
Current: $0.01
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $20
Current: $2.90
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $8 → $4
Current: $1.37
Upside: n/a
Jun 6, 2022
Reiterated: Buy
Price Target: $10
Current: $0.8299
Upside: n/a
May 19, 2022
Reiterated: Buy
Price Target: $18
Current: $6.89
Upside: n/a
May 19, 2022
Reiterated: Buy
Price Target: $16 → $20
Current: $33.07
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $10
Current: $1.13
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $7 → $6
Current: $4.38
Upside: n/a
Apr 7, 2022
Reiterated: Buy
Price Target: $10
Current: $57.68
Upside: n/a
Jan 11, 2022
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $4.71
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $7.75
Upside: n/a
Nov 17, 2021
Reiterated: Buy
Price Target: $30
Current: $18.20
Upside: n/a
Sep 2, 2021
Initiated Coverage: Buy
Price Target: $40
Current: $5.58
Upside: n/a
Feb 17, 2021
Initiated Coverage: Buy
Price Target: $4
Current: $1.26
Upside: n/a